00:00folks you better strap in and get ready
00:01for an exhilarating ride because today
00:03we're uncovering the top five penny
00:05stocks set to Skyrocket in June 20124
00:09each of these picks has a potent
00:10Catalyst a prime setup Insider buying
00:13and or another compelling reason why
00:15they're hot buys right now and you are
00:17in for quite the treat because we have
00:18several stocks with crucial FDA approval
00:21decisions imminent you do not want to
00:23miss out on these potential game
00:24changers so go ahead and grab your pen
00:26and paper folks and we're going to get
00:27right to work time stamps down below and
00:29as always of course make sure to do your
00:31own due diligence on all ideas presented
00:33here on the channel if you're the one
00:34taking the risk you got to be the one
00:35doing the ultimate Frisk lots of people
00:37they get real frisky without thinking
00:39about their risky okay let's start with
00:41number five Lucy luy now Lucy has
00:44several big opportunities coming up and
00:46I'll explain Lucy is innovative eyewear
00:48Inc and it's a company that specializes
00:50in the development and sale of smart
00:52eyeglasses and sunglasses but the reason
00:54that we like her is because she has a
00:56very particular squeeze setup ripe with
00:59ongoing PR catalysts for context on this
01:02we briefed on the lovely Lucy at roughly
01:0424 cents a share last Friday morning and
01:06it proceeded to run to $114 at highs
01:09towards close which was about a 373 per
01:12briefing price to highs run which by the
01:14way cough cough zip Trader used Memorial
01:1650-day Sale is still on if you want to
01:18get 50% off and get access to our daily
01:20morning briefings with all the Catalyst
01:21as well as our step-by-step video
01:23lessons but any who after that massive
01:24run she sold off super aggressively and
01:26had yet another Spike upward today going
01:28another 158% plus by the time of
01:31shooting this video but why did she do
01:33this well she released a Euphoria
01:35garnering PR piece quote Innovative
01:37eyeware Inc launches Eddie Bower smart
01:39eyewear with chat GPT now folks you have
01:42to understand that the way that small
01:43cat markets work is small companies know
01:45that they can drive interest into their
01:47stock by putting out press releases
01:49talking about hot ticket items that's
01:51why companies will often times highlight
01:52their exposure to chat gbt or AI or
01:55crypto or nfts or whatever is hot in
01:57whatever Market you're analyzing them in
01:59and the deal with Lucy is that history
02:00shows that she is very very heavily
02:02prone to frequent and aggressive
02:05Catalyst runs which means that there's a
02:07huge incentive for Lucy's team to keep
02:09putting out these press releases every
02:11time she sells off if the company wants
02:13the stock price to go up well it's very
02:14very easy for them to just go ahead and
02:16put out a press release saying something
02:18about chat GPT or focusing on some
02:20partnership from a year ago and all of a
02:22sudden the stock goes up massively now
02:24of course obviously runs like these and
02:26runs on these types of catalyst runs are
02:28excellent for Traders but a complete
02:30disaster for folks that want to buy hold
02:32and get married so if you're somebody
02:34that wants to trade Lucy is a great
02:37opportunity once you get the next
02:38massive dip if you're somebody that
02:40wants to buy and hold I would avoid Lucy
02:42like the plague penny stocks are great
02:44because of their runs but often times
02:46they make very very bad Partners if
02:48you're going to get married okay number
02:50four ticker symbol GN for Geron
02:53Corporation now GN is a late stage
02:56clinical biopharmaceutical company and
02:58the reason that it made it 2 two days l
02:59list is because it has a Puda action
03:01date AKA FDA approval decision date on
03:05June 16th 2024 this is for a key drug in
03:08their pipeline now remember companies
03:11need FDA approval before they can get to
03:12the market and that is the final stage
03:14to complete marketing and
03:17commercialization the FDA had a
03:18committee vote back in March and the
03:20committee gave it panel approval and the
03:22price doubled and so if we get this
03:24final FDA approval this June on the 16th
03:26it's likely we see an even bigger move
03:28and more so the anticipation up to the
03:30Catalyst can be quite lucrative itself
03:33now obviously anticipatory runs
03:35themselves are a thing regardless of
03:37whether or not we get an approval but in
03:39terms of the odds that we get an
03:40approval well you never know for certain
03:42but at the March meeting quote advisers
03:44to the US FDA backed benefits of Jon's
03:48blood disorder drug saying it outweighed
03:50the risks associated with the treatment
03:52Based on data from a late stage trial
03:54the panel by a wide 12 to2 margin voted
03:57in favor of the benefits of the
03:58injectable drug called IM metel stat
04:01stating the associated risks and
04:03toxicities of the treatment appear to be
04:04manageable but Charlie how far can this
04:07Catalyst Drive the stock well if you
04:08look at the stock right now it had its
04:10original massive Catalyst run in March
04:12and then peaked out at
04:14$430 it since been selling off my next
04:17expectation is that it bottoms out and
04:18starts anticipating and really filling
04:20in for a run heading into the FDA
04:22decision on June 16th then if they get
04:25the approval you get an initial pop and
04:26then a sell on the news and then the
04:28stock adjusts to the approval and finds
04:30itself at a near fair value that takes
04:32into consideration the value that the
04:34company will realize while bringing this
04:35drug to full commercialization so what
04:38price is that at well analyst put the
04:39price target of the stock at an average
04:41of $68 according to tip ranks that
04:44suggests an 87% of upside to the average
04:47the highest price Target is at $10 and
04:49the lowest is at $4.50 six of the
04:51analysts rated it as a buy one as a
04:53whole than zero as a sell in terms of my
04:55thoughts I can see G peing at well over
04:58that analyst average price Target if it
05:00ends up getting the approval next month
05:01will it retain at those levels well
05:04that's unlikely but it should provide a
05:05very very ample trading opportunity my
05:08guess is you get somewhere maybe around
05:10s or 8 and then all of a sudden you get
05:12a big dumpy dumpo and it settles maybe
05:14around5 or $6 okay number three gen fit
05:17ticker symbol gnft now gnft is another
05:20FDA approval play and it is getting some
05:22recognition right now now I'm not a fan
05:23of chasing so I'd argue you want to wait
05:25for a few day dip before considering
05:27buying but nonetheless bigger picture of
05:28the FDA approval decision on this bad
05:30boy is coming June 10th this is for
05:32their ell fror drug and this approval
05:35will lead to the drug coming to Market
05:36and help fund the rest of the company's
05:38pipeline which provides rolling future
05:40Catalyst as well from the CEO quote
05:42approval and commercialization of LF
05:44renor would mean that we would receive
05:46additional milestones and a regular
05:48stream of royalty payments that's the
05:50key part right there royalty payments
05:52which will then be used to finance our
05:54pipeline now mainly focused on acute on
05:57chronic liver failure the company is
05:59also Wellman managed and well
06:00capitalized according to dilution
06:02tracker they have about 86.7 months of
06:04cash left which is excellent for a
06:06company in a money burning field right
06:08this is in the infamously expensive drug
06:11development and FDA trial field very
06:14very expensive process so to have 86.7
06:17months of cash left that's a huge huge
06:19win in terms of price Target analysts
06:21are putting this at an average of $99.50
06:23which is almost 88% of upside from
06:25current trading prices and at the same
06:27time this company is seeing attention
06:28from hedge funds from defense world.net
06:30a hedge fund recently raised its stake
06:32in genfit stock opav holding BV lifted
06:35its position in genfit sa by
06:3822292 in the fourth quarter according to
06:41the company in its most recent 13f
06:43filings with the SEC now why were they
06:46buying this so aggressively well clearly
06:47they see opportunity with the strug in
06:49its pipeline for approval but going back
06:52to the Chart I think the way to play
06:53this is not when it's going parabolic
06:55but rather on a solid dip at least
06:57getting a solid dip we are greedy
06:59Traders we don't want to overpay for
07:01things a 20 to 30% dip opportunity will
07:03likely come within the next few trading
07:05sessions and then all of a sudden you
07:07could start playing it for the next
07:08rally to new all-time highs okay number
07:11two Pineapple energy Inc Peggy this is
07:13one of the lowest price stocks on this
07:15list and perhaps one of the most extreme
07:17potential plays little old Peggy has
07:20been on an overall pumping up uptrend
07:21from 5 cents and there's reason to
07:23believe she's just getting started what
07:25is Peggy though who is Peggy though it
07:27is an emerging company in the renewable
07:29energy sector specializing in
07:30residential solar energy solutions this
07:32company although relatively new presents
07:34a compelling trading opportunity for
07:36several reasons including its Market
07:37potential strategic positioning and the
07:39current undervaluation I'd argue of the
07:42stock of course this operates in a
07:43sector that's rapidly growing renewable
07:45energy and that's expected to expand
07:47significantly over the coming years due
07:49to massive massive government investment
07:51the company's business model centers
07:52around providing comprehensive solar
07:54energy systems for home owners which
07:55include solar panels battery storage and
07:57Energy Management Solutions which if
08:00they aren't already very very heavily
08:01subsidized in most markets will continue
08:03to be more and more heavily subsidized
08:05but all this mumbo jumbo aside look we
08:07could talk about green energy we could
08:08talk about the future and all that kind
08:09of junk but at the end of the day what
08:11I'm interested in is whether or not this
08:13is a stock that has a good enough story
08:15behind it and a low enough valuation
08:18that could bring a wave of Traders and
08:20speculators into it to fill in the gap
08:22between the undervaluation and the fair
08:24value and in my opinion I think the
08:26argument is yes in fact I think that
08:27greedy Traders specifically can
08:29capitalize on Peggy quite a bit the
08:31stock is trading at a significant
08:32discount compared to what I believe is
08:34its intrinsic value which provides a
08:36very nice Arbitrage opportunity for
08:38Swifty and very greedy Traders just to
08:41be quite Frank with you I mean the
08:42undervaluation is largely just due to
08:44the Market's General skepticism towards
08:46small cap companies and emerging
08:47companies however I think that Peggy is
08:49one of the stocks on this list that is
08:51quite appealing because of that because
08:53people are dissing it right now and
08:55because over the medium term you should
08:58start seeing all of a sudden sudden
08:59Peggy report that hey wait a second
09:01we're actually not a garbage company
09:03another factor that makes Peggy quite
09:04appealing is its potential for Rapid
09:06price bikes any kind of positive news
09:07like a strong earnings report a new
09:08partnership or any kind of regulatory
09:10development can cause the stock to go up
09:12quite a lot and has in the past moreover
09:15Peggy has demonstrated surprisingly
09:17strong financial performance and growth
09:18prospects for being such a small Dison
09:21Company the company has consistently
09:23reported increasing revenues and
09:24expanding profit margins indicating
09:26effective cost management and overall
09:28operational efficiency so anyways I
09:29would argue that Peggy while being one
09:31of the more speculative on this list and
09:33definitely the cheapest price per share
09:36well I'd argue that it is ripe it is
09:38absolutely ripe to see more surges
09:40coming in the future and is an excellent
09:42trading opportunity okay Number One X
09:44paying ticker Syble xpv xpv is one of my
09:47favorite penny stocks on the list right
09:48now in terms of a value dip buy
09:50something that you can actually buy and
09:52hold in my view xang Inc xev is a
09:55leading Chinese Electric Vehicle
09:56Manufacturer known for its innovative
09:58and smart EVS the company designs
10:00develops and manufactures a range of
10:01high performance EVS integrating
10:03Advanced software and Hardware
10:05Technologies to enhance Driving
10:06Experience and safety xang is focused on
10:09producing intelligent vehicles that
10:10leverage autonomous driving technology
10:12and smart connectivity features now why
10:14do I like the stock though Charlie
10:15Charlie toell the stock is trading at
10:17multi-year lows despite its fundamentals
10:20consistently improving for example you
10:21go over and you look at xp's financial
10:23performance it's had significant Revenue
10:24growth in Q4 2023 the company reported a
10:27revenue of $1 1.84 billion which marked
10:30a 153.7 year-over-year increase the
10:33vehicle sales revenue surged by 162.5
10:36and Xing is aggressively expanding its
10:38Market reach particularly in Europe
10:40Europa this is a big big reason why
10:42people should be focused on the stock
10:43because the company is really really
10:45making an effort to expand in Europe and
10:47it's working the company has extended
10:48its presence to several European
10:50countries including Germany Yaya deand
10:52France and and the UK this expansion
10:55folks will be pivotal in capturing a
10:56larger share of the global EV market and
10:59driving future growth xbang has also
11:01formed strategic alliances to bolster
11:03its technological and Market position
11:05notably its partnership with Volkswagen
11:07the wagon of the vogs aims to co-develop
11:09Vehicles enhancing xp's credibility and
11:11technological capabilities in the
11:13competitive EV Market such
11:14collaborations are absolutely crucial
11:16for technological advancement and Market
11:18penetration now in terms of deliveries I
11:20mean xping has consistently increased
11:22its vehicle deliveries when you're
11:23looking at the overall bigger picture in
11:25Q4 2023 the company delivered 6,158
11:28vehicles a significant 17.9%
11:31year-over-year increase and that is
11:33pretty good proof of concept if you're
11:35asking me now in terms of margins X
11:36paying is working on improving its gross
11:38profit margins through better product
11:40mix and cost control measures despite a
11:42pricing crunch right now which is
11:43largely driven by all the manufacturers
11:45including Tesla while still the company
11:47has managed to continue to have healthy
11:49profit margins and continue to make
11:50investments to increase them even
11:52further now one of the reasons why I
11:53like X bang especially in the Chinese
11:55market and in the European market is
11:57because of its affordability it just
11:58makes it a lot more accessible when the
12:00car is Affordable and the company plans
12:02to launch a new affordable EV brand with
12:03prices ranging from 14,000 to 21,000 and
12:06this strategy will capture a broader
12:08customer base and drive Mass market
12:10adoption of smart EVs and xang will
12:12bring in the bucks from that in
12:14conclusion xang xev presents a promising
12:16trading opportunity due to its strong
12:19financial performance technological
12:20innovation stretch into the European
12:22market and its market share in China and
12:24the companies focus on affordability and
12:26accessibility will in my opinion help
12:28Drive the stock higher I'm not going to
12:30say that this stock is going to be at
12:31all-time highs anytime soon but what I
12:33will say is that it doesn't deserve to
12:35keep going to newer and newer and lower
12:36and lower low so I would say for sure
12:39take a look at this one do your due
12:40diligence on this one with today's
12:42prices while we're at today's prices
12:43anyways that caps off today's video make
12:45sure to let us know your favorite ones
12:46down below make sure to take advantage
12:48of that Memorial 50 coupon code on zip
12:49Trader you and zip Trader options and
12:51we'll see you in the next video
